IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Clinical antiangiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer
Li, Xiaofan; Xiao, Shaowen; Li, Yongheng; Zhang, Shanwen
关键词Vascular epithelial growth factor (VEGF) recombinant adenovirus-p53 (rAd-p53) advanced cancer hyperthermia radiotherapy
刊名CHINESE JOURNAL OF CANCER RESEARCH
2013-12-01
DOI10.3978/j.issn.1000-9604.2013.12.05
25期:6页:749-755
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]P53 GENE-TRANSFER ; WILD-TYPE P53 ; SQUAMOUS-CELL CARCINOMA ; TUMOR RESPONSE ; LUNG-CANCER ; THERAPY ; CT ; ANGIOGENESIS ; INHIBITION ; HEAD
英文摘要

Objective: To assess the safety and clinical antiangiogenic effect of recombinant adenovirus-p53 (rAd-p53) combined with hyperthermia plus or not plus radiotherapy in advanced cancer.

Methods: Expression of Vascular epithelial growth factor (VEGF) after intratumoral injection of rAd-p53 was assayed by immunohistochemistry (IHC) imaging. Forty-four patients with advanced cancer were enrolled into this clinical study. The patients were intratumorally injected with rAd-p53 (Gendicine) at a dose of 1 x 10(12) vp once a week, with a total of 4-54 (mean 7.7) times. Total of 4-29 (mean 8.5) times of hyperthermia was given to the patients. Among the 44 patients, 30 patients were concurrently added with radiotherapy of a total dose 30-76 Gy/15-38 f/3-8 w (mean 58 Gy).

Results: Before and after intratumoral infection of rAd-p53, the VEGF IHC positive cell scores were 2.80 and 1.50, respectively (P.0.031). The treatment of rAd-p53 combined with hyperthermia plus or not plus radiotherapy in advanced cancer achieved CR rate of 13.60% (6/44), and PR rate of 29.6% (13/44), and thus the effective rate was 43.2%. In addition to 6 patients with CR, 19 patients (19/38, 50.0%) had low density area (LDA) of more than 50% area on CT image within tumor indicating tumor tissue necrosis.

Conclusions: Our data indicate that rAd-p53 inhibits VEGF expression and angiogenesis, and promotes tumor necrosis and shrinkage induced by hyperthermia plus or not plus radiotherapy in advanced cancer.

语种英语
WOS记录号WOS:000329477800017
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59275
专题北京大学临床肿瘤学院
北京大学临床肿瘤学院_肿瘤放疗科
作者单位Peking Univ, Canc Hosp & Inst, Dept Radiotherapy, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
推荐引用方式
GB/T 7714
Li, Xiaofan,Xiao, Shaowen,Li, Yongheng,et al. Clinical antiangiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer[J]. CHINESE JOURNAL OF CANCER RESEARCH,2013,25(6):749-755.
APA Li, Xiaofan,Xiao, Shaowen,Li, Yongheng,&Zhang, Shanwen.(2013).Clinical antiangiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer.CHINESE JOURNAL OF CANCER RESEARCH,25(6),749-755.
MLA Li, Xiaofan,et al."Clinical antiangiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer".CHINESE JOURNAL OF CANCER RESEARCH 25.6(2013):749-755.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Xiaofan]的文章
[Xiao, Shaowen]的文章
[Li, Yongheng]的文章
百度学术
百度学术中相似的文章
[Li, Xiaofan]的文章
[Xiao, Shaowen]的文章
[Li, Yongheng]的文章
必应学术
必应学术中相似的文章
[Li, Xiaofan]的文章
[Xiao, Shaowen]的文章
[Li, Yongheng]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。